Location History:
- Vienna, AT (2013 - 2016)
- Perchtoldsdorf, AT (2019 - 2021)
Company Filing History:
3 out of 1,536 
1 out of 712 
Years Active: 2013-2021
Title: The Innovative Contributions of Rene Georg Ott
Introduction
Rene Georg Ott is a notable inventor based in Perchtoldsdorf, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific binding molecules. With a total of four patents to his name, Ott's work has the potential to impact the treatment of various diseases.
Latest Patents
Ott's latest patents focus on bispecific binding molecules that target both VEGF (Vascular Endothelial Growth Factor) and Ang2 (Angiopoietin 2). These molecules are preferably designed in the form of immunoglobulin single variable domains, such as VHHs and domain antibodies. The patents disclose pharmaceutical compositions containing these binding molecules and their applications in treating diseases associated with VEGF- and/or Ang2-mediated effects on angiogenesis. Additionally, the patents describe nucleic acids encoding these bispecific binding molecules, host cells, and methods for their preparation.
Career Highlights
Throughout his career, Rene Georg Ott has worked with prominent organizations, including Boehringer Ingelheim International GmbH and The Rockefeller University. His experience in these institutions has allowed him to refine his expertise in the field of biotechnology and contribute to groundbreaking research.
Collaborations
Ott has collaborated with esteemed colleagues, including Andreas Gschwind and Joachim Boucneau. These partnerships have fostered an environment of innovation and have led to the advancement of his research.
Conclusion
Rene Georg Ott's contributions to the field of biotechnology, particularly through his patents on bispecific binding molecules, demonstrate his commitment to advancing medical science. His work has the potential to lead to significant improvements in the treatment of diseases related to angiogenesis.